Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-12 Purchase(A) |
2020-12-15 06:02 am |
OncoCyte Corp | OCX | Levine Mitchell S CFO |
10,000 | $2.006 | $20,060 | 13,495 (Direct) |
View |
| 2020-08-03 Purchase |
2020-08-05 7:36 pm |
OncoCyte Corp | OCX | Parker Albert P Chief Operating Officer |
5,000 | $1.3296 | $6,648 | 5,000 (Direct) |
View |
| 2020-08-03 Purchase |
2020-08-05 7:34 pm |
OncoCyte Corp | OCX | KALAJIAN TONY T Sr.VP/Chief Accounting Officer |
5,000 | $1.3066 | $6,533 | 15,000 (Direct) |
View |
| 2020-08-03 Purchase |
2020-08-04 6:50 pm |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
40,000 | $1.347 | $53,880 | 102,698 (Direct) |
View |
| 2020-08-03 Purchase |
2020-08-04 6:47 pm |
OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
10,000 | $1.32 | $13,200 | 36,579 (Direct) |
View |
| 2020-04-24 Purchase |
2020-04-28 6:14 pm |
OncoCyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
1,050,000 | $2.27 | $2,383,500 | 29,435,553 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-11 Option Award |
2020-12-15 06:27 am |
N/A N/A |
OncoCyte Corp | OCX | Last Andrew J. Director |
16,184 | $0 | 23,177 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:25 am |
N/A N/A |
OncoCyte Corp | OCX | Sundar Padmavathi SVP, Marketing & Market Access |
4,177 | $0 | 4,177 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:22 am |
N/A N/A |
OncoCyte Corp | OCX | Ross Douglas T. CMO |
5,317 | $0 | 5,317 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:20 am |
N/A N/A |
OncoCyte Corp | OCX | Parker Albert P COO |
5,586 | $0 | 10,586 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:17 am |
N/A N/A |
OncoCyte Corp | OCX | Redmond Cavan M. Director |
18,416 | $0 | 70,863 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:15 am |
N/A N/A |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
5,909 | $0 | 396,923 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:13 am |
N/A N/A |
OncoCyte Corp | OCX | Levine Mitchell S CFO |
10,121 | $0 | 46,700 (Direct) |
View |
Ownership |
2020-08-31 9:44 pm |
2021-08-24 2030-08-23 |
OncoCyte Corp | OCX | Carter Jennifer L. Director |
0 | $0 | 57,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 5:37 pm |
N/A N/A |
OncoCyte Corp | OCX | Redmond Cavan M. Director |
62,000 | $0 | 62,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 5:34 pm |
N/A N/A |
OncoCyte Corp | OCX | GRIFFITH MELINDA Director |
57,000 | $0 | 57,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 5:34 pm |
N/A N/A |
OncoCyte Corp | OCX | Last Andrew J. Director |
57,000 | $0 | 57,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 5:34 pm |
N/A N/A |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
57,000 | $0 | 57,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 5:31 pm |
N/A N/A |
OncoCyte Corp | OCX | Arno Andrew Director |
57,000 | $0 | 57,000 (Direct) |
View |
| 2020-05-07 Option Award |
2020-05-12 2:25 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
106,221 | $0 | 106,221 (Direct) |
View |
| 2020-04-28 Option Award(A) |
2020-04-30 8:08 pm |
N/A N/A |
OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-04-28 Option Award |
2020-04-30 5:53 pm |
N/A N/A |
OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
20,000 | $0 | 20,000 (Direct) |
View |